Avenue Therapeutics, Inc. (ATXI) vs ZyVersa Therapeutics, Inc. (ZVSA)

Avenue Therapeutics, Inc. and ZyVersa Therapeutics, Inc. are both Biotechnology companies. ZyVersa Therapeutics, Inc. is the larger, with a market value of $970.0K against $680.0K — 1.4× the size. Across the 7 metrics below, Avenue Therapeutics, Inc. leads on 5 and ZyVersa Therapeutics, Inc. on 2.

Valuation

Metric ATXI ZVSA Biotechnology median
P/E n/m n/m 7.88
P/S n/m n/m 11.47
P/B 2.90 n/m 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales n/m n/m 10.73
Earnings yield (170.00%) (3,679.60%) (28.84%)
Free cash flow yield (84.01%) (511.54%) (23.03%)

Profitability

Metric ATXI ZVSA Biotechnology median
Gross margin — 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (163.30%) 817.13% (57.72%)
Return on assets (90.50%) (225.42%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ATXI ZVSA Biotechnology median
Revenue growth (TTM) — — 5.64%
EPS growth (last fiscal year) 89.70% 50.71% —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ATXI ZVSA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 1.40 0.05 4.73
Net debt to EBITDA 0.93 0.00 0.96

Dividend

Metric ATXI ZVSA Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 — 0.00

Size

Metric ATXI ZVSA Biotechnology median
Market cap 680.00k 970.00k 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack